Medication info

Arosartan Tablet 5/100 Milligrams

Prescription medicationTabletOralExpired
Ingredient · strength
Amlodipine Besylate›6.944mg / 1 tabletLosartan Potassium›100mg / 1 tablet
Manufacturer / importer
Ilhwa Co., Ltd.
Appearance
Pale pink rectangular film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Expired

MFDS item code 201903026 · Approved 2019.05.10

This product's status changed to Expired on 2024.05.10. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Initial treatment of stage 2 hypertension or essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual components as follows, switching directly to this medicine may be considered. - 5/50 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 50 milligrams monotherapy. - 5/100 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 100 milligrams monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should be made based on factors such as baseline blood pressure, target blood pressure, and the expected extent of achieving the treatment target with the combination product compared with monotherapy. The usual dose is 5/50 milligrams once daily; if blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 milligrams once daily. ○ Patients with renal impairment: Dose adjustment is not necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min), but use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced effective intravascular volume: Use of this medicine is not recommended in a small number of patients with reduced effective intravascular volume (e.g., patients receiving treatment with high-dose diuretics). (See Section 1. Warnings under Precautions for Use.) ○ Patients with hepatic impairment: Use of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 milligrams once daily). ○ Elderly patients: For elderly patients aged 75 years or older, an initial losartan dose of 25 milligrams once daily is recommended; therefore, use of this medicine as initial therapy is not recommended.
Child dose
○ Pediatric patients: The safety and efficacy of this drug have not been established in pediatric patients aged 18 years or younger; use of this drug is not recommended.

Ingredients

Manufacturer
Ilhwa Co., Ltd.

Efficacy & effects

Initial treatment of stage 2 hypertension or essential hypertension not controlled with monotherapy

  • Essential hypertension
  • stage 2 hypertension
View approved original text

This medication is used in patients with essential hypertension when blood pressure cannot be sufficiently controlled with monotherapy of amlodipine or losartan. It is also used in stage 2 hypertensive patients who need to start combination therapy from the beginning to reach the target blood pressure. In summary, this medication effectively lowers blood pressure and helps manage hypertension.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual components as follows, switching directly to this medicine may be considered. - 5/50 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 50 milligrams monotherapy. - 5/100 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 100 milligrams monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should be made based on factors such as baseline blood pressure, target blood pressure, and the expected extent of achieving the treatment target with the combination product compared with monotherapy. The usual dose is 5/50 milligrams once daily; if blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 milligrams once daily. ○ Patients with renal impairment: Dose adjustment is not necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min), but use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced effective intravascular volume: Use of this medicine is not recommended in a small number of patients with reduced effective intravascular volume (e.g., patients receiving treatment with high-dose diuretics). (See Section 1. Warnings under Precautions for Use.) ○ Patients with hepatic impairment: Use of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 milligrams once daily). ○ Elderly patients: For elderly patients aged 75 years or older, an initial losartan dose of 25 milligrams once daily is recommended; therefore, use of this medicine as initial therapy is not recommended.

Child dose

○ Pediatric patients: The safety and efficacy of this drug have not been established in pediatric patients aged 18 years or younger; use of this drug is not recommended.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. Caution is necessary when administering to patients with low blood volume, as hypotension may occur upon initial dosing. It should not be administered to patients with allergies to this medication or related drugs, pregnant or breastfeeding women, patients with severe liver dysfunction, patients with heart valve diseases, or those in a state of shock. The drug should be used with caution in patients with low blood volume or those requiring strict sodium restriction, patients with severely impaired kidney function, and patients with high serum potassium levels. There may be side effects such as dizziness, headache, drowsiness, dyspepsia, and edema, so caution is needed when driving or operating machinery. Patients with reduced liver or kidney function may have increased drug concentrations, so they should consult their physician before taking this medication. Caution is advised when taken with potassium-sparing diuretics or potassium supplements, as serum potassium levels may become dangerously high. When used with other antihypertensives, the blood pressure-lowering effect may become excessively strong; hence, it must be taken according to the physician's instructions. Pregnant or nursing women should not take this medication, and especially during pregnancy, there may be serious risks to fetal health, so consultation with healthcare professionals is vital before deciding to take it. In cases of overdose, severe hypotension, tachycardia, and shock may occur, thus requiring immediate medical attention for appropriate treatment. This medication is not recommended for children and adolescents under 18 years, as its safety and efficacy have not been established. For elderly patients with reduced kidney function, initial dosage adjustment may be necessary, and it is important to consult a physician before taking this medication. While taking this medication, regular checks of blood pressure, kidney function, liver function, and electrolyte levels should be conducted to ensure there are no abnormalities. This medication should be kept out of the reach of children and should not be transferred to another container to maintain quality.

Side effects

  • Hypotension
  • congenital skull formation impairment
  • anuria
  • renal failure
  • oligohydramnios
  • fetal limb hypoplasia
  • craniofacial malformation
  • pulmonary hypoplasia
  • premature
  • intrauterine growth restriction
Show 180 more
  • patent ductus arteriosus
  • dizziness
  • headache
  • drowsiness
  • cerebral infarction
  • weakness
  • chest discomfort
  • chest pain
  • early satiety
  • peripheral edema
  • pitting edema
  • abdominal discomfort
  • dyspepsia
  • nausea
  • gastroesophageal reflux disease
  • constipation
  • pruritus
  • urticaria
  • palpitations
  • flushing
  • orthostatic hypotension
  • facial flushing
  • dyspnea
  • cough
  • dizziness (vertigo)
  • conjunctival injection
  • frequency of urination
  • fatigue
  • edema
  • vasculitis
  • tension headache
  • sensory loss
  • paresthesia
  • peripheral neuropathy
  • syncope
  • taste disturbance
  • tremors
  • erectile dysfunction
  • gynecomastia
  • changes in bowel habits
  • dry mouth
  • gastritis
  • gingival hypertrophy
  • pancreatitis
  • vomiting
  • hyperglycemia
  • arthralgia
  • low back pain
  • muscle cramps
  • myalgia
  • leukopenia
  • thrombocytopenia
  • insomnia
  • mood changes
  • rhinitis
  • hair loss
  • increased sweating
  • purpura
  • skin discoloration
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbances
  • increased urination frequency
  • urination disorders
  • nocturia
  • hepatitis
  • jaundice
  • increased liver enzyme levels
  • pruritus
  • rash
  • angioedema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • sinoatrial block
  • atrioventricular block
  • abdominal discomfort
  • precordial pain
  • diarrhea
  • loose stools
  • skin hyperemia
  • maculopapular rash
  • malaise
  • warmth
  • impaired glucose tolerance
  • weakness
  • muscle cramps
  • low back pain
  • limb pain
  • congestion
  • upper respiratory tract infection
  • sinusitis
  • diarrhea
  • sinus disorder
  • pharyngitis
  • myalgia
  • insomnia
  • edema
  • abdominal pain
  • angioedema
  • skin desquamation
  • hemolysis
  • facial edema
  • fever
  • orthostatic effects
  • angina pectoris
  • second-degree atrioventricular block
  • cerebrovascular accident
  • hypotension
  • atrial fibrillation
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • loss of appetite
  • toothache
  • flatus
  • gastritis
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle rigidity
  • arthritis
  • fibromyalgia
  • myasthenia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory decline
  • decreased libido
  • memory disorders
  • migraine
  • neuropathy
  • panic disorder
  • sleep disorders
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • rhinitis
  • respiratory congestion
  • dermatitis
  • dry skin
  • petechial hemorrhage
  • erythema
  • photosensitivity
  • rash
  • sweating
  • urticaria
  • blurred vision
  • eye burning and pain
  • conjunctivitis
  • dysgeusia
  • tinnitus
  • decreased vision
  • nocturia
  • urethral infection
  • dry cough
  • liver dysfunction
  • fatigue
  • rhabdomyolysis
  • taste disturbance
  • erythroderma
  • hyperkalemia
  • hyponatremia
  • elevated ALT
  • elevated serum creatinine
  • elevated liver enzymes
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • anaphylactic syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is recommended to maintain a storage temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

Pale pink rectangular film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.